Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta).

Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB.

J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):207-20.

PMID:
11873070
2.

Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.

Tarantal AF, Marthas ML, Shaw JP, Cundy K, Bischofberger N.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):323-33.

PMID:
10096575
3.

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.

Van Rompay KK, Brignolo LL, Meyer DJ, Jerome C, Tarara R, Spinner A, Hamilton M, Hirst LL, Bennett DR, Canfield DR, Dearman TG, Von Morgenland W, Allen PC, Valverde C, Castillo AB, Martin RB, Samii VF, Bendele R, Desjardins J, Marthas ML, Pedersen NC, Bischofberger N.

Antimicrob Agents Chemother. 2004 May;48(5):1469-87. Erratum in: Antimicrob Agents Chemother. 2994 Jan;48(6):2346.

4.

Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta).

Castillo AB, Tarantal AF, Watnik MR, Martin RB.

J Orthop Res. 2002 Nov;20(6):1185-9.

5.

Direct administration of insulin-like growth factor to fetal rhesus monkeys (Macaca mulatta).

Tarantal AF, Hunter MK, Gargosky SE.

Endocrinology. 1997 Aug;138(8):3349-58.

PMID:
9231787
6.

Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

Metzner KJ, Binley JM, Gettie A, Marx P, Nixon DF, Connor RI.

Retrovirology. 2006 Dec 21;3:97.

7.

Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML.

J Infect Dis. 2001 Aug 15;184(4):429-38. Epub 2001 Jul 16.

8.
9.
12.

Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta).

Prahalada S, Tarantal AF, Harris GS, Ellsworth KP, Clarke AP, Skiles GL, MacKenzie KI, Kruk LF, Ablin DS, Cukierski MA, Peter CP, vanZwieten MJ, Hendrickx AG.

Teratology. 1997 Feb;55(2):119-31.

PMID:
9143092
13.

Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.

Magierowska M, Bernardin F, Garg S, Staprans S, Miller MD, Van Rompay KK, Delwart EL.

J Virol. 2004 Mar;78(5):2434-44.

14.

Extended treatment with tenofovir disoproxil fumarate in treatment-experienced HIV-1-infected patients: genotypic, phenotypic, and rebound analyses.

Margot NA, Isaacson E, McGowan I, Cheng A, Miller MD.

J Acquir Immune Defic Syndr. 2003 May 1;33(1):15-21.

PMID:
12792350
15.

Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):116.

PMID:
19637428
16.

Transplacental pharmacokinetics and fetal distribution of 2', 3'-didehydro-3'-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques.

Patterson TA, Binienda ZK, Newport GD, Lipe GW, Gillam MP, Slikker W Jr, Sandberg JA.

Teratology. 2000 Aug;62(2):93-9.

PMID:
10931506
17.

Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.

Van Rompay KK, Johnson JA, Blackwood EJ, Singh RP, Lipscomb J, Matthews TB, Marthas ML, Pedersen NC, Bischofberger N, Heneine W, North TW.

Retrovirology. 2007 Apr 6;4:25.

18.

Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.

Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML.

J Infect Dis. 2002 Nov 15;186(10):1508-13. Epub 2002 Oct 29.

19.

The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters.

Van Rompay KK, Singh RP, Brignolo LL, Lawson JR, Schmidt KA, Pahar B, Canfield DR, Tarara RP, Sodora DL, Bischofberger N, Marthas ML.

J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):900-14.

PMID:
15220696
20.

Fetal development in rhesus monkeys exposed prenatally to cocaine.

Howell LL, Schama KF, Ellis JE, Grimley PJ, Kitchens AJ, Byrd LD.

Neurotoxicol Teratol. 2001 Mar-Apr;23(2):133-40.

PMID:
11348830
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk